Impaired insulin-stimulated myosin phosphatase rho-interacting protein signaling in diabetic goto-kakizaki vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 302, Issue 9, 2012, Pages

  Lee, Jin Hee ^a,b   Palaia, Thomas ^a   Ragolia, Louis ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Insulin resistance; Myosin binding subunit of myosin phosphatase; Signaling pathways

Indexed keywords

INSULIN; MYOSIN LIGHT CHAIN PHOSPHATASE; MYOSIN PHOSPHATASE 1; MYOSIN PHOSPHATASE RHO INTERACTING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; GTP-BINDING PROTEINS; GTPASE-ACTIVATING PROTEINS; IMMUNOPRECIPITATION; INSULIN; MICROFILAMENT PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN PHOSPHATASE 1; RATS; RATS, INBRED WKY; SIGNAL TRANSDUCTION; VASODILATION;

ADENOVIRIDAE; RATTUS;

EID: 84860525566     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00254.2011     Document Type: Article

References (38)

1. Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson L. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 7: 1034-1038, 2000.
2. Begum N, Duddy N, Sandu O, Reinzie J, Ragolia L. Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signaling pathways. Mol Endocrinol 14: 1365-1376, 2000.
3. Begum N, Ragolia L. Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats. Metabolism 47: 54-62, 1998.
4. Begum N, Ragolia L, Rienzie J, McCarthy M, Duddy N. Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension. J Biol Chem 273: 25164-25170, 1998.
5. Begum N, Sandu OA, Duddy N. Negative regulation of Rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: role of nitric oxide and cyclic guanosine monophosphate signaling pathways. Diabetes 51: 2256-2263, 2002.
6. Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A. Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 277: 6214-6222, 2002.
7. Chen XQ, Tan I, Ng CH, Hall C, Lim L, Leung T. Characterization of RhoA-binding kinase ROKa implication of the pleckstrin homology domain in ROKa function using region-specific antibodies. J Biol Chem 277: 12680-12688, 2002.
8. Colwell J, Jokl R. Diabetes Mellitus: Theory and Practice. Norwalk, CT: Appleton and Lange, 1996.
9. Eto M, Senba S, Morita F, Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410: 356-360, 1997.
10. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274: 37385-37390, 1999.
11. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39, 2001.
12. Gebbink MF, Kranenburg O, Poland M, van Horck FP, Houssa B, Moolenaar WH. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J Cell Biol 137: 1603-1613, 1997.
13. Gong M, Fuglsang A, Alessi D, Kobayashi S, Cohen P, Somlyo A, Somlyo A. Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. J Biol Chem 267: 21492-21498, 1992.
14. Hartshorne D, Ito M, Erdödi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 19: 325-341, 1998.
15. Hsueh W, Law R. Insulin signaling in the arterial wall. Am J Cardiol 84: 21J-24J, 1999.
16. Ichikawa K, Ito M, Hartshorne DJ. Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem 271: 4733-4740, 1996.
17. Kahn AM, Allen JC, Seidel CL, Zhang S. Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase. Hypertension 35: 303-306, 2000.
18. Kahn AM, Husid A, Allen JC, Seidel CL, Song T. Insulin acutely inhibits cultured vascular smooth muscle cell contraction by a nitric oxide synthase-dependent pathway. Hypertension 30: 928-933, 1997.
19. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248, 1996.
20. Kitazawa T, Eto M, Woodsome TP, Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
21. 2+ sensitization in Triton X-100-demem-branated rabbit arterial smooth muscle. J Physiol 520: 139-152, 1999.
22. Koga Y, Ikebe M. p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoA. J Biol Chem 280: 4983-4991, 2005.
23. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 272: 12257-12260, 1997.
24. Lee JH, Palaia T, Ragolia L. Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am J Physiol Cell Physiol 296: C327-C338, 2009.
25. Lee JH, Ragolia L. AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am J Physiol Cell Physiol 291: C1355-C1365, 2006.
26. Lee JH, Xia S, Ragolia L. Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats. Am J Physiol Regul Integr Comp Physiol 295: R144-R154, 2008.
27. Mulder J, Poland M, Gebbink MF, Calafat J, Moolenaar WH, Kranenburg O. p116Rip is a novel filamentous actin-binding protein. J Biol Chem 278: 27216-27223, 2003.
28. Okon E, Szado T, Laher I, McManus B, van Breemen C. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40: 520-530, 2003.
29. Okubo S, Ito M, Takashiba Y, Ichikawa K, Miyahara M, Shimizu H, Konishi T, Shima H, Nagao M, Hartshorne D, Nakano T. A regulatory subunit of smooth muscle myosin bound phosphatase. Biochem Biophys Res Commun 200: 429-434, 1994.
30. Riddick N, Ohtani K, Surks H. Targeting by myosin phosphatase-RhoA interacting protein mediates RhoA/ROCK regulation of myosin phospha-tase. J Cell Biochem 103: 1158-1170, 2008.
31. Sandu O, Ragolia L, Begum N. Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes 49: 2178-2189, 2000.
32. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411-418, 2003.
33. Somlyo A, Somlyo A. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
34. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37: 1053-1059, 2001.
35. Surks HK, Richards CT, Mendelsohn ME. Myosin phosphatase-Rho interacting protein: a new member of the myosin phosphatase Complex That Directly Binds RhoA. J Biol Chem 278: 51484-51493, 2003.
36. Surks HK, Riddick N, Ohtani K. M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells. J Biol Chem 280: 42543-42551, 2005.
37. Sward K, Mita M, Wilson D, Deng J, Susnjar M, Walsh M. The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep 5: 66-72, 2003.
38. Trinkle-Mulcahy L, Ichikawa K, Hartshorne DJ, Siegman MJ, Butler TM. Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in alpha-toxin-permeabilized smooth muscle. J Biol Chem 270: 18191-18194, 1995.